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In mammalian females, germ cells proliferate exclusively in development resulting in 
a finite number of oocytes at birth which are kept in a dormant state within primordial 
follicles. The ovarian reserve (OR) is the population of primordial follicles and is 
highly variable between individuals. The OR is continually depleted to exhaustion in 
mammals, which results in menopausal onset in humans. However, infertility in both 
species is onset prior to complete exhaustion of ovarian reserve. It is hypothesised 
that both the initial size of the OR and the rates of depletion contribute to determine 
reproductive lifespan however current knowledge of these links is limited. Current 
ovarian reserve data is from histological cross-sectional studies or indirect correlative 
measures (eg. Anti-Müllerian Hormone). Here we assess the efficacy of a new 
transgenic-fluorescence mouse model as a non-invasive longitudinal method of 
quantifying the ovarian reserve to determine these contributions. Using a germ-cell 
specific (Ddx4) driven Cre-recombinase coupled with a stop-floxed fluorescent 
reporter transgene (tdTomato), for fluorescent expression exclusively in oocytes. 
Resultant fluorescent images were image processed for quantification of primordial 
follicle fluorescence only and these measures correlated against stereological 
primordial follicle counts (n=13) to assess the efficacy of the proposed fluorescent 
model. These variables had a strong positive correlation (r=0.8783 p<0.0001) 
illustrating the efficacy of fluorescence quantification as a correlative measure of 
ovarian reserve size. This fluorescent correlative measure of ovarian reserve can be 
used for fertility studies to perform rank correlation to stereological primordial follicle 
counts from the same individuals in later life. Thus representing the first longitudinal 
measure of the ovarian reserve to determine the contribution of the initial ovarian 
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 Women have a finite period in which they are reproductively capable. Modern family 
planning has resulted in the trend of women delaying their first childbirth until their 
early-mid thirties. These changes have been attributed to increased female 
education rates and career aspirations (Broekmans et al. 2006, Hollander & Breen 
1990, Pelosi et al. 2015).  
At ~30 years of age, women begin a period of subfertility. (Broekmans 2009). This 
results in an increased incidence of age related infertility and thus an increase in 
reliance of assisted reproductive technologies (ARTs) such as in vitro fertilisation 
(IVF). Thus an increased understanding of the mechanisms underpinning age-
related infertility will be beneficial as trends continue to delay childbearing.  
 
1.2 Female germ cells and the ovarian reserve  
1.2.1 Primordial Germ Cells 
In mammals, primordial germ cells are oocyte precursors which, during 
development, migrate from the primitive streak, through the endoderm and to the 
genital ridge where they differentiate into oogonia and undergo extensive 
proliferation (Maheshwari & Fowler 2008, Richardson & Lehmann 2010). Oogonia 
then begin to undergo meiosis to form oocytes which are suspended at Prophase I. 
At initiation of meiosis, pluripotency and mitotic capabilities are lost resulting in a 
finite store of oocytes that can no longer proliferate (Maheshwari & Fowler 2008, 
Stoop et al. 2005, Vaskivuo et al. 2001). Thus, at meiotic onset the final number of 
oocytes of an individual is determined.  
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1.2.2 The ovarian reserve 
The finite store of oocytes are encapsulated in a layer of squamous granulosa cells 
forming primordial follicles. The ovarian reserve is the number of primordial follicles 
present in the ovary of an individual (Kerr et al. 2013). Primordial follicles remain in a 
dormant state of suspended meiosis until either programmed cell death or activation 
out of the reserve for further follicular development (folliculogenesis) (Hsueh et al. 
1994, Richardson et al. 1987). Variations during development results in highly 
variable ovarian reserve sizes between individuals (recorded up to 20-fold) at birth 
(Monniaux et al. 2014, Pankhurst 2017, Wallace & Kelsey 2010).  
 
1.2.3 Ovarian reserve exhaustion 
The finite ovarian reserve is continually depleted to exhaustion resulting in ovarian 
reserve depletion in mice and menopause in humans. Menopause onset results in 
the cessation of menstrual cyclicity and the loss of endogenous estrogens (Atsma et 
al. 2006, Charleston et al. 2007, de Bruin et al. 2001, Gougeon et al. 1994, 
Richardson et al. 1987). The loss of endogenous hormones results in increased risk 
of cardiovascular disease, osteoporosis and other health risks, often requiring 
treatments such as hormone replacement therapy (HRT) (Braem et al. 2013, Snieder 
et al. 1998, Treloar et al. 1998).  Menopause is experienced by ~50% of the 
population and thus an increased understanding of the mechanism determining 
menopausal onset will be beneficial in trying to mitigate linked health risks.  
 
Menopause onset occurs at ~51 years of age but this is highly variable within the 
population, records range from 40-60 years of age (Braem et al. 2013, Charleston et 
al. 2007, Faddy et al. 1992, Wallace & Kelsey 2010). Lifestyle factors such as 
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smoking and obesity are reported to contribute only a minimal proportion of the 
observed variation of age at menopause onset (de Bruin et al. 2001, van Noord et al. 
1997). Thus, it is postulated that the onset of menopause is dependent on the initial 
size of the ovarian reserve (de Bruin et al. 2001).  
 
1.3 Depletion of the ovarian reserve 
1.3.1 Depletion overview 
In humans, the proliferation of female germ cells occurs exclusively in development 
reaching a peak at approximately 5 months post conception with the average woman 
having an ovarian reserve capacity of approximately 7 million germ cells at this time 
(Fig.1.1). At birth this number has been significantly depleted to approximately 2 
million germ cells (Baker & Zuckerman 1963, Forabosco et al. 1991, Hsueh et al. 
1994). At pubertal onset (~14), only approximately 400,000 follicles exist in the 
ovarian reserve (Baker & Zuckerman 1963, Hsueh et al. 1994, Wallace & Kelsey 
2010). The average woman will only ovulate approximately 400 oocytes in her 
lifetime, an amount significantly smaller than her ovarian reserve capacity (Baker & 
Zuckerman 1963, Monniaux et al. 2014). The ovarian reserve is continually depleted 
exponentially until exhaustion and menopausal onset, the permanent cessation of 
the menstrual cycle (Charleston et al. 2007, Wallace & Kelsey 2010). The ovarian 
reserve is exponentially depleted by the apoptotic cell process of follicular atresia 





1.3.2 Follicular atresia 
Less than 0.1% of all follicles will ovulate during a women’s lifetime. All follicles that 
do not ovulate will undergo follicular atresia, an apoptotic cell process. During 
development, the population of oocytes decreases dramatically by atresia from peak 
of ~7x106 to only ~2x106 at birth, hypothesised to select out poor quality oocytes 
(Coucouvanis et al. 1993, Hsueh et al. 1994). In post-natal life, a selection of 
granulosa cells of primordial follicles will undergo apoptosis leading to breakdown of 
the encapsulated oocyte and exit from the ovarian reserve (Depalo et al. 2003, 
Vaskivuo & Tapanainen 2003). Developing follicles recruited for folliculogenesis that 
do not appropriately respond to hormone signalling also undergo follicular atresia by 
apoptosis (Vaskivuo et al. 2001, Vaskivuo & Tapanainen 2003). The majority of 
follicles undergo atresia, thus suggesting that the rates at which follicles degrade 
may influence the age at which the ovarian reserve becomes exhausted. 
Figure 1.1:Wallace-Kelsey Model (2010) illustrating a constructed 
mathematical model of ovarian reserve depletion from historical 
histological data 
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1.3.3 Activation of Primordial Follicles for Folliculogenesis 
The other mechanism of ovarian reserve depletion is the activation of primordial 
follicles from their dormant state for folliculogenesis, the maturation of the ovarian 
follicle (Bonnet et al. 2013, Monniaux et al. 2014). Once activated, the follicle has 
permanently left the ovarian reserve.  Activation of primordial follicles occurs at 
different rates in relation to age (Faddy & Gosden 1996, Faddy et al. 1992, Monniaux 
et al. 2014, Wallace & Kelsey 2010). The varying rates of depletion by activation is 
hypothesised to underpin the changes involved in the different reproductive 
capabilities with age (te Velde & Pearson 2002). Irregular menstrual cyclicity in the 
lead up to menopausal onset is hypothesised to occur as a result of declining antral 
follicle populations as a result of diminishing ovarian reserve size with age. In age-
matched comparisons, sterile, irregularly cycling women contain approximately 10-
fold less follicles than their still regularly cycling counterparts (Faddy & Gosden 1996, 
Richardson et al. 1987).  This data implicates rates of activation in combination with 
the initial size of the ovarian reserve as mechanisms regulating the way the ovarian 
reserve is depleted with age. However, the magnitude of contribution of each factor 
is limited by the current methods available to study ovarian reserve.  
 
1.4 Infertility and the Ovarian reserve 
 
The clinical definition of fertility is the ability to naturally conceive within 12 months of 
actively trying. Subfertility is classified as failure to achieve pregnancy in the same 
period of time (te Velde & Pearson 2002). Women experience subfertility and 
infertility prior to complete ovarian reserve exhaustion. The majority of women are 
clinically fertile in their twenties but the proportion of women with subfertility steadily 
increases during fourth decade of life (CECOS Fédération et al. 1982, Hollander & 
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Breen 1990, te Velde & Pearson 2002). The average woman is infertile by her early 
forties, which is approximately 10 years prior to complete ovarian reserve exhaustion 
and menopause onset (Baker & Zuckerman 1963, Monniaux et al. 2014). This 
illustrates that the size of the ovarian reserve in early life is not the exclusive factor 
determining age-related infertility onset.  
 
1.5 Current knowledge of the ovarian reserve 
There are no direct measures of the ovarian reserve as a result of the quiescent 
nature of primordial follicles (Kevenaar et al. 2006). Therefore, current knowledge of 
the ovarian reserve originates from correlations of indirect ovarian reserve markers 
and invasive stereological measures.   
 
1.5.1 Histological Data  
 
Data on true primordial follicle counts comes exclusively from stereological counts 
from donated whole ovary tissue, from surgery or autopsy (Broekmans et al. 2009).  
This results in primordial follicle population data from a single point in time which is 
then extrapolated and compared to other samples to produce mathematical models 
of ovarian reserve depletion and fertility (Baker & Zuckerman 1963, Block 1952, 
Block 1953, Gougeon & Chainy 1987, Richardson et al. 1987).  Menopause is also 
used as a retrospective marker to infer previous fertility (Depmann et al. 2015). The 
different studies are often inconsistent in their methodology such as applied 
correction methods for counting and biological assumptions applied for best fit of 
their proposed model (Hansen et al. 2008).  Studies have been undertaken which 
combine large amounts of histological data from previous studies to infer new 
models of depletion rates of the ovarian reserve (Faddy et al. 1992, Hansen et al. 
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2008, Wallace & Kelsey 2010). These studies combine the same or similar 
histological data but produce disputing models of primordial follicle activation rates 
with age. This highlights the limitations of cross-sectional data of ovarian reserve and 
highlights the potential value of a method which could study the ovarian reserve 
longitudinally.  
 
1.5.2 Ovarian volume  
 
The lack of measures of the ovarian reserve results in a gap in knowledge in our 
understanding of the link between ovarian reserve depletion and fertility. Partial 
ovarian biopsies and ovarian volume measurements were proposed as screening 
methods to assess ovarian reserve in infertile women. Ovarian volume by 
transvaginal sonography as a marker for the size of the ovarian reserve was 
proposed but proved imprecise, making it clinically irrelevant as a measure of 
ovarian reserve (Brett et al. 2009, Wallace & Kelsey 2004).  
 
1.5.3 Ovarian biopsies 
 
Another method proposed to quantify the ovarian reserve of a living patient was 
partial ovarian biopsy (Lass et al. 1997). Ovarian biopsies are often cryopreserved in 
young cancer patients to preserve fertility; however, this procedure remains 
experimental. Partial ovarian biopsy as an ovarian reserve measure was an invasive 
procedure that hypothesised a uniform distribution of follicles throughout the ovary, 
resulting in a representative population of the ovarian reserve from biopsy (Faddy & 
Gosden 1996, Sharara & Scott 2004). Further research showed that follicles are 
randomly distributed in the ovary meaning that a random biopsy would not truly 
reflect the ovarian reserve (Qu et al. 2000, Schmidt et al. 2003). This random 
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distribution represents a potential limitation to be addressed in the design of future 
ovarian reserve quantification experiments.  
 
1.5.4 Indirect correlations of the ovarian reserve 
Currently, assessing ovarian reserve capacities at an individual level are done by 
indirect, non-invasive measures such as antral follicle count (AFC) and serum Anti-
Müllerian hormone (AMH) levels (Depmann et al. 2015). Transvaginal sonography is 
used to assess AFC and AMH levels can be detected from a blood sample.  Anti-
Müllerian hormone (AMH) is produced exclusively by the granulosa cells of 
developing follicles in adult mammalian females (Broer et al. 2014). Amh–/– mice 
experience premature depletion of their ovarian reserves, implicating AMH as a 
regulator of primordial follicle activation rates (Carlsson et al. 2006, Durlinger et al. 
2002, Durlinger et al. 1999). AMH is used clinically as a ‘fertility marker’ to assess 
the number of growing follicles. AMH and AFC use this correlative relationship 
between developing follicles and primordial follicles to infer the size of the ovarian 
reserve (Jirge 2011, Knauff et al. 2009, van Rooij et al. 2005). AMH levels decrease 
with age, due to reduced follicular activation from a smaller primordial follicle pool 
(Kevenaar et al. 2006). AMH is currently the best clinical measure of ovarian reserve 
to study different reproductive health conditions (Broer et al. 2014). AMH does not 
exhibit variability with the menstrual cycle like other proposed ovarian reserve 
endocrine markers (eg. Follicle stimulating hormone (FSH), inhibin) (Jirge 2011).  In 
humans, AMH levels do not exhibit decline with age until after peak concentration at 
~25 (Fleming et al. 2012, Hagen et al. 2010, Kelsey et al. 2011). Thus, in humans 
AMH is not a reliable ovarian reserve marker in early life.  
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Current techniques to study ovarian reserve implicate both initial ovarian reserve 
size and rates of ovarian reserve depletion as factors contributing to age-related 
infertility and menopausal onset. These techniques are limited in that they cannot 
determine the magnitude to which these factors contribute to these ovarian reserve 
depletion events. This results in a gap in knowledge about whether initial ovarian 
reserve size or rate of ovarian reserve depletion is the most important determinant of 
sterility onset and menopausal onset.  
 
1.6 Oocyte quality 
 
Age-related infertility is attributed to declining ovarian reserve as well oocyte quality. 
Aneuploidy, the incorrect segregation of chromosomes during oocyte meiosis, is a 
measure of oocyte quality and is the leading cause of miscarriage in older women 
(22). The incidence of oocyte aneuploidy increases with age (Battaglia et al. 1996). 
Studies using young donor eggs in older mothers show that aged uteri still have the 
ability to maintain pregnancy implicating the quality of the aged oocyte as a limiting 
factor of pregnancy in older women (Navot et al. 1991). There are minimal methods 
for assessing oocyte quality in vivo (te Velde & Pearson 2002). Further 
characterisation of the relationship between ovarian reserve size and reproductive 







1.7 Oogonial Stem Cells: Fact of Fiction 
 
There is a prevailing dogma of a dormant non-renewable primordial follicle 
population (for up to 40-50 years of age in humans). This has recently been 
challenged with the proposal of the existence of oogonial stem cells (OSC’s) within 
the adult mice ovary (Johnson et al. 2005, Johnson et al. 2004). It is proposed that 
these putative mitotically active OSCs replace themselves within the reserve over 
time dismissing the proposed dormancy of meiotic machinery  (Johnson et al. 2004, 
Zou et al. 2009).  OSCs in the adult ovary remain controversial but depletion events 
are still occurring resulting in menopause and age-related infertility (Byskov et al. 
2005, Kerr et al. 2013). This illustrates the importance of the dormant primordial 
follicle populations in ovarian reserve depletion and oocyte quality with age. Ovarian 
reserve depletion models from histological data sets that allow for neo-genesis are 
less concordant than those with a finite ovarian reserve (Wallace & Kelsey 2010). 
The theory of OSC’s replacing dormant primordial follicles is also inconsistent with 
the increasing incidence of poor-quality oocytes with age suggesting that if OSC’s 
could replace themselves, this pattern would not occur.  
 
1.8 Mouse model of the ovarian reserve 
 
Mice are a common model of the ovarian reserve due to a finite store of primordial 
follicles which decline with age resulting in reproductive senescence, a model for 
menopause (Caligioni 2009, Finch et al. 1984). Female mice gain reproductive 
capabilities at approximately 40-45 days after birth which acts as a model for puberty 
(Paris et al. 1973). Mice, with decreased litter size as a marker of fertility decline, 
exhibit a continuous decline in fertility with age which is concordant with the declining 
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primordial follicle populations in the same period (Gosden et al. 1983, Jones & Krohn 
1961). The reproductive cycle of the mice is known as oestrus and when this 
becomes irregular it is a good marker for irregular menstrual cyclicity and infertility 
onset in humans (Brinton 2012, Finch et al. 1984). Mice have a much shorter 
lifespan than humans so these transitions occur over a shorter time period which is 
advantageous in terms of experimental aims but is limited in that these time periods 
are substantially shorter (Brinton 2012). Mouse lines are commonly used as models 
due to their efficiencies in knocking down genes as well as transgene insertion for 
labelling (Caligioni 2009). Thus, the mouse model of the ovarian reserve can 
increase understanding of the mechanisms of the ovarian reserve.  
 
1.9 Candidate Transgenic Germ Cell Marker 
 
The quiescent nature of the ovarian reserve results in a lack of molecular markers for 
primordial follicle identification, resulting in difficulties in studying the ovarian reserve 
(Lass et al. 1997, Monniaux et al. 2014). Recent studies have identified a gene, 
DEAD[Asp-Glu-Ala-Asp]-box polypeptide 4 (Ddx4), an RNA helicase expressed 
exclusively in germ cells and highly conserved between species (Hickford et al. 
2011, Raz 2000). Ddx4 represents a transgenic promoter for use in a transgenic 
model of ovarian reserve allowing for primordial follicle germ cell identification 
(Gallardo et al. 2007).  
 
1.10 Cre-Lox Recombination 
 
The Cre-Lox recombination system allows for site-specific recombination. Cre-
recombinase is coupled to a promoter resulting in site-specific recombination of 
floxed sequences (flanked by LoxP sites) exclusively in cells expressing the specific 
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gene. A stop-floxed fluorescent reporter gene (eg.tdTomato) coupled with a germ-
cell specific (Ddx4) driven Cre would result in fluorescent expression exclusively in 
germ cells (Fig. 1.2). The floxed premature stop codon in tdTomato reporter 
transgene prevents tdTomato expression in somatic cells which do not express 
Ddx4. Ddx4 promoter driven Cre-recombinase recombines at floxed stop codon 
allowing tdTomato fluorescent expression in germ cells (Gallardo et al. 2007, Gassei 
et al. 2017, Park & Tilly 2015). This presents a transgenic model for in vivo 
assessment of the ovarian reserve.  
 
Both the sperm and oocyte express the germ cell marker, Ddx4. The breeding 
strategy (Fig. 1.3) involved the father expressing the Ddx4-Cre, this strategy was 
necessary because oocytes have the ability to store mRNA resulting in Cre-
recombinase presence in the oocyte leading to premature recombination of 
functional LoxPtdTomato in all tissues (Gallardo et al. 2007). The breeding strategy 




Figure 1.2: Ddx4 promoter driven Cre-recombinase coupled with stop floxed 




Figure 1.3: Breeding strategy involved in the generation of Ddx4CreTg/0-




Current ovarian reserve knowledge is limited due to the quiescent nature of 
primordial follicles.  A longitudinal measure of ovarian reserve would represent a key 
step in understanding the links between both initial ovarian reserve size and rates of 
ovarian reserve depletion on reproductive lifespan and menopausal onset.   
 
The proposed Ddx4CreTg/0-LoxPtdTomatoTg/0 model was assessed as a fluorescent 
transgenic marker for ovarian reserve size at post-natal day 25 (P25) for early life 
quantification of ovarian reserve. This was assessed by comparison to stereological 
primordial follicle counts (the ovarian reserve). The Ddx4CreTg/0-LoxPtdTomatoTg/0 
model represents a proposed transgenic marker of ovarian reserve to allow for 
longitudinal ovarian reserve studies.  
 
An increased understanding into whether initial ovarian reserve size or rates of 
ovarian reserve depletion is the primary determinant of onset of infertility and 
menopausal onset will be beneficial in developing possible therapies to delay 
infertility. This knowledge can also be used to track when menopause will occur to 




1.12 Aims and Hypothesis 
 
The Ddx4CreTg/0-LoxPtdTomato Tg/0 model presents a novel method to study ovarian 
reserve size longitudinally. A link between ovarian reserve size in early life and 
fertility has been inferred but is not well-characterised due to lack of primordial follicle 
markers.  
 
In this pilot study we aim to assess the efficacy of a fluorescent model of the ovarian 
reserve. The aims of this research were: 
1. To investigate an image processing method to allow for the quantification of 
primordial follicles only from Ddx4CreTg/0-LoxPtdTomato Tg/0 fluorescent 
images; 
2. To assess if Ddx4CreTg/0-LoxPtdTomato Tg/0 fluorescence correlates to ovarian 
reserve by comparison to primordial follicle counts as determined by 
stereological methods;  
3. To assess the efficacy of the Ddx4CreTg/0-LoxPtdTomato Tg/0 model compared 
to serum AMH concentrations as a marker of ovarian reserve in P25 mice.  
 
 
Fluorescence allows for the quantification of cell populations therefore the 
hypothesis was that Ddx4Cre-LoxPtdTomato fluorescence would correlate to ovarian 





2.1 The animal model  
2.1.1 Animals 
 
Mice were housed in conditions of controlled light-dark conditions with free access to 
water and standard rodent chow at all times. Two male Ddx4-Cre mice (FVB-
Tg(Ddx4-cre)1Dcas/J; Stock#006954;)(Gallardo et al. 2007), and two female 
LoxPtdTomato mice (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J; Stock#007914) 
(Madisen et al. 2010) were sourced from Jax Mice, The Jackson Laboratory (Bar 
Harbour, Maine, USA). Sourced Ddx4-Cre males were from a FVB genetic 
background while sourced female LoxPtdTomato individuals were from a C57BL/B6 
genetic background. Both strains were backcrossed against C57BL/B6 wildtype mice 
from pre-existing colonies in Pankhurst lab. All animal experiment protocols were 
approved by The University of Otago Ethics Committee.  
 
2.1.2 Generating the fluorescent model 
Ddx4CreTg/0 males were bred with LoxPtdTomatoTg/0 females to produce Ddx4CreTg/0 
x LoxPtdTomatoTg/0 offspring. Both the sperm and oocyte express the germ cell 
marker, Ddx4. The breeding strategy involved the father expressing the Ddx4-Cre, 
this strategy was necessary because oocytes have the ability to store mRNA 
resulting in Cre-recombinase presence in the oocyte leading to premature 





2.2 Genotyping for Ddx4CreTg/0-LoxPtdTomatoTg/0 
individuals 
 
2.2.1 DNA extraction  
Ear punch samples from female offspring of Ddx4CreTg/0 x LoxPtdTomatoTg/0 matings 
were collected at Day 14. A master mix of 0.4 mL Lysis buffer (100mM Tris pH 8.5; 
5mM EDTA; 200mM NaCl, 0.2% SDS) and 2.8 µL of 20mg/mL Proteinase K per 
reaction to ensure uniformity for the samples was created. 0.4 mL of this lysis buffer 
reaction mix was then added to each labelled microcentrifuge tube containing a 
single ear sample. The samples were then digested on a 55°C heated block 
overnight. Tubes were then agitated and centrifuged at 14,500 rpm for 10 minutes. 
The resulting supernatant was then transferred into a new labelled tube containing 
0.4 mL isopropanol and was centrifuged at 14,500 g for 5 minutes to pellet the DNA. 
The resulting supernatant was poured off and discarded and the tube containing the 
pellet left to dry on a paper towel for 10-15 minutes.  The pellet was then 
resuspended with 0.3 mL TE buffer (10 mM Tris pH 8.5; 1 mM EDTA) and vortexed 
to ensure the DNA had properly dissolved. These DNA samples were then used for 
genotyping by Polymerase Chain Reaction (PCR) and Gel Electrophoresis or stored 
at -20°C. 
 
2.2.2 Genotyping by Polymerase Chain Reaction (PCR) 
The reagents required for genotyping by PCR were combined into a master mix for 
the number of reactions being undertaken to ensure uniformity of the reaction mix 
(Table 1). Master mixes were created for a DNA control, Ddx4-Cre and 
LoxPtdTomato. The DNA control was a Ddx4 control to test for the presence of DNA 
in the samples. In a PCR strip tube, 2 µL of the DNA samples was added to 18 µL of 
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the master mix for each respective marker. Each reaction also contained a positive, 
negative and water control (mice expressing the transgene, negative for the 
transgene and Diethyl pyrocarbonate-treated (DEPC) H2O, respectively). Primer 
information is shown in Table 2, sourced from Integrated DNA Technologies (IDT, 
Coralville, Iowa, USA). The PCR protocol was run on a Thermocycler (Biometra), 
these conditions were preheat at 94°C for 3 minutes followed 35 cycles of template 
denaturation (94°C for 30 seconds), primer annealing (67°C for 1 minute) and primer 
extension (72°C for 1 minute), next held at 72°C for 2 minutes and finally held at 
10°C until used for gel electrophoresis. These PCR conditions were optimised for the 
Ddx4-Cre primers Table 2 but were also appropriate temperatures for the 
LoxPtdTomato and DNA control primers.   
 
2.2.3 Genotyping by Gel Electrophoresis 
Confirmation of PCR results was achieved by running the resultant PCR products on 
a 1.5% agarose gel. An agarose gel was prepared by combining 1.35 g of agarose 
with 81 mL of dH2O in a conical flask and microwaving for 30 seconds. Next, 9 mL of 
TBE (0.45 mM Tris Base; 0.45 M Boric acid, 10 mM EDTA-Na2) was added and the 
mixture was microwaved for a further 40 seconds. Lastly, 4.5 µL of GelRed® 
(Biotium), a fluorescent nucleic acid stain, was added and the flask swirled to mix 
and then immediately poured into a gel plate with combs and left to set for 30 
minutes. The set gel was loaded into an electrophoresis tank and covered in 
Electrophoresis Buffer (1:10 dilution of 5x TBE). 5 µL of 1 KB DNA ladder was 
loaded into the left hand well of both rows as a reference to ensure the resultant 
PCR product size matched the primer product length (Table 2). Alongside this, 10 µL 
of each PCR product was loaded. The electrophoresis tank was run on 100 V for 50 
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minutes and the results were captured via a Biorad mini transilluminator (Biometra) 
and photographed with a Canon PowerShot G3 via BioDoc analyse 2.0 software 
(Biometra).  Samples expressing the trangenes were propagated by PCR, stained by 
the fluorescent nucleic acid dye, GelRed ® and visible under the ultra-violet light.  
The breeding strategy involved used parents who were hemizygous for the 
transgene. Thus, the presence of a band illustrated that sample was Tg/0 and no 
band 0/0 for the transgene. Samples expressing both transgenes were identified as 
Ddx4CreTg/0-LoxPtdTomatoTg/0 and were used as models for these experiments. 
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Table 1: PCR Master Mix 
a) 10mM dNTPs: diluted from 100mM dNTP set (Invitrogen, Cat#10297-018) 
b) ThermoPol Reaction Buffer:(NEW ENGLAND Biolabs, Cat#B9004S) 
 
 
Table 2: Primer Sequence Information for PCR 
  
Reagents µL/reaction 
DEPC Ultrapure dH2O 11.1 µL 
Forward Primer 0.5 µL 
Reverse Primer 0.5 µL 
10mM dNTPs 0.4 µL 
10 x ThermoPol reaction buffer (Mg2+) 2.0 µL 
6 x Cresol Red- sucrose stock 3.3 µL 
Taq DNA polymerase 5 units/µl 0.2 µL 
Total 18 µL 
PCR 
Reaction 












324 bp 54.7°C 
55.2°C 
Ddx4-Cre Tg Fwd:CACGTGCAGCCGTTTAAGCCGCGT 
Rev:TTCCCATTCTAAACAACACCCTGAA 






XM_030243530.1 196 bp 54.2°C 
55.8°C 
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2.3 Tissue Collection  
2.3.1 Preparations for Dissection 
Females Ddx4CreTg/-LoxPtdTomatoTg/0 individuals were culled at 25 days of age with 
a terminal dosage of Ketamine at 225 mg/kg (PheonixPharm Cat#DSO6/11) and 
Domitor at 3 mg/kg (Pfizer,Cat#107332-8) administered intraperitoneally. Loss of 
pedal withdrawal reflexes was used to confirm that the mice were sufficiently 
sedated. This dosage euthanised the mouse after sample extraction.   
 
2.3.2 Cardiac Puncture  
A midline incision was made just below the base of the sternum. This was then 
extended laterally in both directions cutting through both the skin and abdominal 
wall. The diaphragm was identified and blunt dissected away to expose the heart. 
Ribs were cut up at each side to give better access to the heart. Blood was then 
slowly aspirated from the right ventricle and transferred to a microcentrifuge tube 
where it sat at room temperature for ~1hour to clot.  
 
2.3.3 Serum Sample Collection 
Clotted blood collected by cardiac puncture was then spun down in a microcentrifuge 
(Eppendorf MiniSpin® plus) at 14,000 rpm for 10 minutes. The resulting serum 
supernatant was carefully pipetted off the top and transferred to a new tube, being 
careful not to disturb the clotted blood products. Serum samples were then stored at 




2.3.4 Ovary Dissection 
 
Ovaries were then dissected one at a time by exposing the abdomen from the 
original cut site. The ovarian fat pad and uterus were cut to excise the ovary from the 
body cavity and placed under a dissecting microscope (Olympus SZ51) under low 
light to dissect away the remaining adipose and the oviduct. The ovary was then 
placed in a small petri dish of warmed PBS (37°C) and taken into the dark 
microscope room while limiting light exposure to the ovary. The ovary was then 
imaged immediately (please see ‘Imaging the Fluorescent Ovaries’ section below). 
The second ovary was then dissected out using the same procedures.  
 
2.4 Imaging the Fluorescent Ovaries 
 
2.4.1 Equipment Used to Capture Fluorescent Images 
Ovaries were placed under the Nikon SMZ18 stereomicroscope on a with a Okolab 
H401-T-Controller microscope incubator stage preheated to 37.5°C to prolong tissue 
viability.  A Nikon C-HGFI Intensilight Precentered Fiber Illuminator which uses a 
mercury lamp was used as the source of illumination. This was turned on at least 10 
minutes prior to the first image being taken. The camera used was a DS-Ri2 
microscope camera and was visualised on the Nikon NIS-Elements Software.  
 
2.4.2 Capturing Fluorescent Images 
 
The original images were taken with both Fast (Focus) and Quality (Capture) 
settings set to 3x8bit 1636x1088, Neutral Density (ND)=16 and an analog gain of 
1.2x at exposure times 800ms,1s, 2s, 3s, 4s and 10s. In subsequent litters, images 
could not be captured at these settings and analog gain and neutral density were 
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adjusted to allow for fluorescent image capture. Fluorescent images were then 
analysed in Image J to quantify fluorescence intensity disparities. 
 
2.5 Tissue Processing 
 
2.5.1 Wax Processing and Embedding of Ovaries 
Once imaged, the ovaries were placed in 1mL of Bouins fixative (75 mL saturated 
piric acid, 25 mL Paraformaldehyde 40%, 5 mL glacial acetic acid for 24 hours at 
room temperature. The Bouins fixative was then replaced with 1 mL of 70% ethanol 
and stored at 4°C until processing. Tissues were then placed in cassettes between 
foam layers and sample processing for wax-infiltration was contracted to OMNI 
Histology Unit, Department of Pathology, University of Otago (ThermoScientific, 
Excelsior ES).  
 
2.6 Image Processing  
2.6.1 Ilastik software 
Ilastik is an open-source image classification and segmentation software.  
Appropriate predetermined images were treated as a stack in Image J and then 
saved as image sequences and input into an Ilastik ‘Pixel Classification’ document 
as individual images for image training. Feature’s selected were all from s=0.7 and 
s=1.0, this totals 12 features, one each of Gaussian Smoothing, Laplacian of 
Gaussian, Gaussian Gradient Magnitude, Difference of Gaussians, Structure Tensor 
Eigenvalues and Hessian of Gaussian Eigenvalues for both selected sigma values. 
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2.6.2 Image Training 
Optimisation of image training techniques was undertaken to determine image input 
type for training, level of training required and most efficient feature selections. 
Image training used four differently coloured labels to manually identify by 
brushstroke a selection of each of the four features: Developing follicles, Primordial 
follicles, other ovarian structures and background. This methodology transforms this 
manual classification input and transforms it to an unbiased uniform output by 
machine learning. Optimisation of image training techniques was performed to 
process fluorescent images with the aim to identify primordial follicle fluorescence 
only to quantify against stereological primordial counts.  
 
2.7 Stereology and Histology  
 
2.7.1 Tissue Sectioning 
Wax embedded samples were then mounted onto the microtome (Leica RM 2025) 
and serial sections of the entire ovary were taken at 5 µm. Five consecutive sections 
were taken to create a ribbon, these ribbons were then floated in a bath of 30% 
ethanol for approximately 1 minute and then transferred via a microscope slide into a 
38°C water bath for another ~1 minute. These ribbons were then mounted onto a 
glass slide directly from the water bath and left to dry raised on a heat block.  
 
2.7.2 Dewaxing, Haematoxylin and Eosin Staining of Ovaries.  
Sectioned tissues were then dewaxed using the protocol outlined in  
Table 3. They remained in 70% ethanol until they were ready to be stained by 
Haematoxylin and Eosin (H&E). H&E protocol is outlined (Table 4). Slides were 
taken from Xylene 2 and immediately coverslipped with Dibutylphthalate Polystyrene 
Xylene (DPX) used as a mountant and left to dry overnight.  
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Table 3: Dewaxing Protocol 
Solution Duration 
100% Xylene 1 2 minutes 
100% Xylene 2 2 minutes 
100% Xylene 3 2 minutes 
100% Ethanol 1 2 minutes 
100% Ethanol 2 2 minutes 
95% Ethanol  2 minutes 




Table 4: Protocol for Haematoxylin and Eosin Staining 
Solution Duration 
Distilled Water, 2 x changes 10 dips each 
Mayer’s Haematoxylin (60:40 dilution) 00:01:00 
Tap water, 2 x changes 10 dips each 
Scott’s Tap Water 00:02:00 
Tap water, 2 x changes 10 dips each 
Eosin 00:01:00 
Running Tap Water 00:04:30 
70% Ethanol 00:00:30 
90% Ethanol 00:00:30 
100% Ethanol 1 00:00:30 
100% Ethanol 2 00:00:30 
100% Xylene 1 00:02:00 
100% Xylene 2 00:02:00 
  
1) Scott’s Tap Water (0.166M MgSO4, 23.8mM NaHCO3) 
2) Mayer’s Haematoxylin (1mM NaIO3, 1.9mM AlK(SO4)2, 3.3mM Haematoxylin, 
0.35M Glacial Acetic Acid) 
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2.8 Follicle Counts  
2.8.1 Stereological Follicles Counts 
Physical dissector stereology was used to count primordial follicles with every 10th 
section used as the reference and every 11th section as the look-up section. 
Primordial follicles were counted if their nucleus was present in the reference section 
but not the look up section. The look up section improves accuracy so that follicles 
are not overcounted. Primordial follicles were defined by either a complete or 
incomplete layer of surrounding squamous granulosa cells. Any presence of cuboidal 
granulosa cell presence excluded that cell from primordial follicle classification as it 
was seen to have begun the process of recruitment out of the ovarian reserve and 
was classified as a primary follicle. Primary follicle counts were also obtained but 
these counts occurred independently of primordial follicle counts of same sample. 
Each count was multiplied by 10, for the number of sections it represented and 
totalled. Each ovary was treated as a separate sample for correlation to image 
fluorescence but combined with the other ovary of the same individual (if applicable) 
for AMH correlations.  
 
2.8.2 Developing Follicle Counts 
 
Developing follicles were individually counted manually using ImageJ cell counter 
software of image captured expressed fluorescence. Any cells larger than the 
putative primordial follicles were included. These counts were then correlated to 
AMH, fluorescence quantification data and primordial follicle counts.  
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2.8.3 Fluorescent Image Primordial Follicle Counts 
Putative primordial follicles were also counted using Image J cell counter software of 
image captured expressed fluorescence. These counts were then correlated to 
stereological primordial follicle counts and fluorescence quantification data.  
 
2.9 AMH Enzyme-Linked Immunosorbent Assay (ELISA) 
2.9.1 Protocol 
An AMH (Rat and Mouse) ELISA kit was sourced from Ansh Labs (Webster, Texas, 
USA, Cat# AL-113). Samples to be used were originally diluted 1:10 with Sample 
Dilutent and the maximum calibrator concentration was 13 ng/mL which was serially 
diluted six times in addition to a blank for standard curve construction. It was 
hypothesised that AMH levels would be within these parameters in 25 day old mice, 
but levels within six mice were not. In the second ELISA, the highest calibrator 
concentration was 26 ng/mL and serum samples were diluted 1:20 and 1:100 with 
repeats for each. The manufacturers protocol was then followed. 
Tetramethylbenzidine (TMB) Chromogen Solution from kit was added with a 10 
second gap between addition to each column, the stopping solution (0.2M sulfuric 
acid) was added in the same 10 second increments for equal timed reactions.   
 
2.9.2 Analysing ELISA Results 
The plate was read by SpectraMax® i3x within 20 minutes of the stopping solution 
being added. The absorbance was read at 450nm, the wavelength that TMB is 
excited and detected at and at 615nm which is outside the absorbance-range of 
TMB, for background-correction (absorbance = A450nm-A650nm). ELISA sample 
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2.10 Statistical Analysis  
 
Pearson-correlations were used to compare stereological primordial follicle counts to 
primordial follicle fluorescence quantification, AMH, stereological primary follicle 
counts and fluorescent image counts of primordial follicles. Pearson-correlations 
were also used to compare fluorescence quantification to fluorescent image counts 
and AMH to developing follicle counts. These analyses were done using Prism 8, 
Graphpad Software with  p<0.05 denoting significance. Pearsons correlation co-
efficient (r) measured the strength of the linear relationship, with r>0.8 denoting a 





3.1 Recombination Efficacy of Cre-Lox Model 
3.1.1 Expression of tdTomato in Ddx4CreTg/0-LoxPtdTomato Tg/0 samples 
 
Five individuals from the first litters of the two initial breeding pairs were Ddx4CreTg/0-
LoxPtdTomato Tg/0, all of these individuals expressed tdTomato exclusively in their 
germ cells when dissected ovaries were viewed under the fluorescent 
stereomicroscope (Fig 3.1 A-B).  
 
3.1.2 Follicular Distribution in Ddx4CreTg/0-LoxPtdTomato Tg/0 fluorescent 
ovaries  
 
Figure 3.1 C is a magnified image of Ddx4CreTg/0-LoxPtdTomato Tg/0 fluorescent 
ovaries at postnatal day 25 (P25).  This illustrates larger fluorescent oocytes in 
isolation and smaller fluorescent primordial follicle oocytes clustered together. The 
distribution of the fluorescent Ddx4CreTg/0-LoxPtdTomato Tg/0 oocytes is concordant 
with follicle distribution illustrated in histological sections of Ddx4CreTg/0-
LoxPtdTomato Tg/0 (Fig. 3.1E-F). Figure 3.1E illustrates the distribution of oocytes of 
larger developing follicles throughout the ovary which is present in corresponding 
germ cell fluorescence expression images (Fig. 3.1A-D). Figure 3.1F illustrates a 
magnified view of a histological section of Ddx4CreTg/0-LoxPtdTomato Tg/0 ovary 
exhibiting primordial follicles with squamous granulosa cells only (arrow) and primary 
follicles with presence of cuboidal granulosa cell/s (arrowhead). These primordial 
follicles are often located in clusters in the periphery of the ovary which is consistent 
with both the histological image in Figure 3.1F and fluorescent primordial follicle 























Figure 3.1: Figure 3.1: Ddx4CreTg/0-LoxPtdTomato Tg/0 fluorescent ovary images 
and histological H&E stained sections illustrating follicle distribution 
throughout the ovary. 
A) Ddx4CreTg/0-LoxPtdTomato Tg/0 (P25) ovary exhibiting targeted tdTomato 
fluorescence exclusively in germ cells. B) Ddx4CreTg/0-LoxPtdTomatoTg/0 (P25) ovary 
exhibiting targeted tdTomato fluorescence exclusively in germ cells. C) Magnification 
of A, illustrating follicular distribution D) Magnification of B, illustrating fluorescent 
follicular distribution and focussing issues in imaging of 3D structures. E) 
Haematoxylin and Eosin stained Ddx4CreTg/0-LoxPtdTomatoTg/0 whole ovary section 
(5µm) illustrating the distribution of developing follicles (arrows) throughout the ovary. 
F) Magnification of Ddx4CreTg/0-LoxPtdTomatoTg/0  whole ovary section (5 µm) 
exhibiting primordial follicles with squamous granulosa cells only (arrow) and primary 
follicles with presence of cuboidal granulosa cell/s (arrowhead). Scale bar=250 µm 
(A-E); F=25 µm. 
 32 
3.1.3 Ddx4CreTg/0-LoxPtdTomato Tg/0 fluorescent features 
Figures 3.1A-D exhibit transparency allowing for the visualisation of follicles 
throughout the ovary.  Figure 3.1D illustrates the difficulties in focussing all areas of 
the ovary in a single image, illustrated by the out of focus appearance of some 
follicles. Figure 3.1D also illustrates a magnified view of Ddx4CreTg/0-LoxPtdTomato 
Tg/0 ovary exhibiting a larger population of putative primordial follicles when compared 
to Figure 3.1C illustrating the variation in ovarian reserve sizes between individuals 
(Baker & Zuckerman 1963).  
 
3.1.4 Global Recombination of Ddx4CreTg/0-LoxPtdTomato Tg/0 samples 
 
Ddx4CreTg/0-LoxPtdTomatoTg/0 individuals of the second litters of these breeding 
pairs all showed tdTomato expression throughout all tissues of their ovaries when 
imaged (Fig. 3.2A and 3.2C). To determine the cause of somatic-cell tdTomato 
expression, an ear, spleen and uterine sample were also dissected out and imaged 
under the fluorescent stereomicroscope. These tissues also expressed tdTomato 
(Fig. 3.2B and 3.2D). These results show global recombination, the expression of 


















Figure 3.2: Global recombination of Ddx4CreTg/0-LoxPtdTomato Tg/0 samples exhibiting tdTomato expression in all 
tissue 
A) Ddx4CreTg/0-LoxPtdTomato Tg/0 ovary (P25) exhibiting expression of tdTomato throughout the ovary. B)  Spleen, ear and uterine 
sample of the individual in (A) exhibiting global expression of tdTomato. C) Ddx4CreTg/0-LoxPtdTomato Tg/0 ovary (P25) exhibiting 
expression of tdTomato throughout the ovary. D)  Spleen, ear and uterine sample of the individual in (C) exhibiting global 
expression of tdTomato. Scale bar=250 µm(A-C); D=125 µm. 
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3.2 Determining cause of recombination inefficiencies 
3.2.1 Maternal inheritance of recombined LoxPtdTomato 
The premature stop codon upstream of the tdTomato transgene prevents the 
expression of tdTomato if Cre-recombinase is not present. To determine if the 
tdTomato transgene had undergone recombination in the absence of Cre-
recombinase, two Ddx4Cre0/0-LoxPtdTomatoTg/0 littermates were dissected and 
imaged as above. There was no fluorescence emitted by 
Ddx4Cre0/0LoxPtdTomatoTg/0 samples indicating that the LoxPtdTomato site had 
not undergone random recombination in the absence of Cre-recombinase.  
 
3.2.2 Parental Age Effect 
To determine if the cause of global recombination of tdTomato was a parental age 
effect, a breeding strategies were arranged (Table 5). These results illustrate 
paternal age as a determining factor for global recombination but that this effect is 
not fully penetrant as illustrated by Ddx4CreTg/0-LoxPtdTomato Tg/0.  
 
The breeding strategy of Ddx4CreTg/0-LoxPtdTomato Tg/0 model always involved a 
paternal carrier of Ddx4-Cre due to oocytes ability to store mRNA resulting in Cre-
recombinase presence in the zygote and thus global recombination (Gallardo et 
al. 2007). These parental age breeding experiments suggest that sperm is 
contributing mRNA during fertilisation, leading to premature Ddx4-Cre expression 
in the zygote resulting in global recombination(Hosken & Hodgson 2014). Thus, all 
future breeding involved a young, virgin Ddx4-CreTg/0 father resulting in some 
Ddx4CreTg/0-LoxPtdTomato Tg/0 offspring expressing global recombination and 
others exhibiting germ cell specific tdTomato expression.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
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(40-57 days of age at 
mating) 
Old Mother 
(78-196 days of age at 
mating) 
 
Young Father  






offspring all exhibited 
germ cell specific 
tdTomato fluorescence 







offspring all exhibited 
germ cell specific 
tdTomato fluorescence 

















a) Young mother denotes mother arranged for breeding from 40 days of age, 
the onset of reproductive capabilities.  
b) Young father denotes father arranged for breeding from 42 days of age. 
c) Old mother and old father describe animals who have already produced at 




3.3.1 Image Focussing 
Image capture of the ovary was performed on a single ventral surface only. As 
illustrated above in Figure 3.1, Ddx4CreTg/0-LoxPtdTomato Tg/0 fluorescent ovaries 
appear transparent under the fluorescent stereomicroscope allowing for the 
imaging of fluorescent follicles throughout the ovary. Figure 3.1D illustrates the 
difficulty in focusing in all areas simultaneously. To mitigate issues regarding focal 
planes, camera focus settings were adjusted in real time but limiting light exposure 
time to mitigate potential of photobleaching.  
 
3.3.2 Fluorescence Intensity Disparities between samples 
The fluorescent image-capture procedures remained constant for all samples, yet 
fluorescent intensities fluctuated between samples (Fig. 3.3). This would implicate 
biological variation as the cause of these observed differences. It was not clear if 
the pixel-classification software would be able to distinguish similar features 
across a range of differing fluorescence intensities (Fig 3.3). The effect of differing 
fluorescence intensities were to be assessed during the next phase of the 




Figure 3.3: Visualisation and Quantification of fluorescent intensities disparities from histogram between Ddx4CreTg/0-
LoxPtdTomatoTg/0 samples. 
A) Ddx4CreTg/0-LoxPtdTomato Tg/0 (P25) ovary exhibiting targeted tdTomato fluorescence exclusively in germ cells. B) Number of 
pixels counted at each intensity value from (A). C) Cumulative counts of intensity values band width of 10 (from B). D) Ddx4CreTg/0-
LoxPtdTomato Tg/0 (P25) ovary exhibiting targeted tdTomato fluorescence exclusively in germ cells. E) Number of pixels counted at 
each intensity value from (D) illustrating decreased fluorescent intensity compared to (A) F) Cumulative counts of intensity values- 
band width of 10.  
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Image Processing  
3.3.3 Ilastik Inputs 
Ilastik is an image classification and segmentation software, suggesting a quality 
candidate to achieve experimental aims of classification of fluorescent primordial 
follicles only. Ilastik was trialled using different types of fluorescent images to 
assess which image type would be the most user friendly for both manual training 
and the software. Red channel only images with appropriate training, were able to 
identify primordial follicle fluorescence most efficiently compared to other trialled 
image inputs for manual training.  
 
3.3.4 Image training with Ilastik 
Ilastik image training was optimised to determine the best methodology to allow 
for primordial follicle fluorescence quantification. Changes to Pixel Classification 
settings did not result in significant changes to outputs. However, increased and 
more targeted training resulted in improvements in primordial follicle fluorescence 
quantification. Figure 3.4A illustrates early and middle optimisation of Ilastik 
training and Figure 3.4A-B and 3.4E-F illustrate the relationship between the 
quality of image training and the ability of the software to predict what the 
remainder of the structures are in the image from the manual training.  
 
Figure 3.4F illustrates more defined primordial follicle identification by 
fluorescence as a result of the increased training (Fig. 3.4E). Increased overall 
manual training in combination with improved manual training at primordial follicles 
borders to distinguish them from the rest of the ovary resulted in improved image 
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processing protocol sensitivity but as evident by Figure 3.4E-F was still lacking in 
desired specificity.  
 
This illustrates components of troubleshooting undertaken which determined that 
this image type (Fig. 3.4E) for input for manual image training was not suitable.  
 
3.3.5 Ilastik Prediction Export 
Ilastik output is probability based. The software converts the primordial follicle 
training and predicts the probability of pixels belonging to primordial follicles 
structures or not. Figure 3.4C and 3.4G illustrate these prediction exports, black 
denotes strong prediction of the pixels belonging to primordial follicles and white 
fairly certain the pixels do not . There is also a gradient of grey with varying 
degrees of primordial follicle prediction based off of the black to white scale.   
 
Figure 3.4G illustrates areas of uncertainty(grey) around developing follicle 
peripheries, a feature common in most samples. These areas should not be 
included for primordial follicle fluorescence quantification and therefore protocols 
were improved, using ImageJ, to remove areas of uncertainty so that only true 








Figure 3.4 Image Processing for Fluorescence Quantification Optimisation 
 A)Magnification of Red Channel only Ddx4CreTg/0-LoxPtdTomato Tg/0 image illustrating early, 
minimal manual image training. B) Early Ilastik Predictive Export from training in A exhibiting poor 
definition between structures. Blue is the label for putative primordial follicles. C) Ilastik 
Probabilities Export of Blue Label. D) Early progress thresholding of Ilastik probabilities export 
exhibiting poor distinction between developing and primordial follicles. E) Gaussian Blurred 
fluorescent image with improved image training. White arrow and arrowhead are the same 
locations as corresponding black on F. F) Improved Ilastik predictive export from training in E. 
Black arrow and arrowhead indicate areas predicted to be primordial follicles that are not indicating 
training not yet sufficient. G) Ilastik Probabilities export from training of E. H) Thresholding of G in 
attempt to refine out uncertainties but retain all primordial follicle identifications.  
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3.3.6 Optimisation of Image Processing Procedure for Fluorescence 
Quantification 
 
Figure 3.5 illustrates the process for final fluorescence quantification. Manual 
training was performed on two images, one with a lower mean intensity and one 
with a higher mean intensity. All applied training was then collated into a training 
profile by the software and applied to each fluorescent image. The training profile 
created a mask over all the fluorescent images which allowed for tweaking of 
training if some images had putative primordial follicles not identified. These 
additional manual training tweaks were then added to the training profile in real 
time. This removes the concern of disparities in fluorescence intensities between 
images. Figure 3.5A illustrates the final training on one of training images, yellow 
is the merged labels of all non-primordial follicle structures to allow for primordial 
follicle only predictive export (Fig. 3.5C). Figure 3.5B illustrates prediction from 
labels input in Figure 3.5A exhibiting clear definition between cells.  
 
3.3.7 Primordial Follicle Quantification  
Figure 3.5D illustrated the product of Figure 3.5C thresholding. Exported Ilastik 
Probability exports were all made binary in ImageJ to remove areas of grey 
uncertainty.  
 
The resultant images used an image-mask to generate a region of interest. The 
area of the generated region of interest was then calculated to produce the 
fluorescence quantification used for comparison to stereological primordial follicle 
counts and image primordial follicle counts.  
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A)Image training of split channel (red) image, blue is putative primordial follicles. Yellow label has 
been merged previously B) Predictive export from training from A. C) Corresponding Ilastik 
Probabilities export from training in A. D) Binary Thresholding of C, for creation of image mask for 
area calculation of region of interest.  
 
Figure 3.5: Exemplar of optimised Image Processing for fluorescence quantification 
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3.4 Assessing Image Processing Efficacy 
3.4.1 Comparison of original images to fluorescence quantification images 
Figure 3.6 illustrates fluorescent samples (both a high and low population of 
primordial follicles)  alongside an overlay of the resultant fluorescence 
quantification image to assess efficacy (Fig 3.6B and 3.6E). This illustrated the 
image processing protocols ability to identify primordial follicle fluorescence only. 
Magnification of these overlays illustrated in Figures 3.6C and 3.6F exhibits that 
the image processing protocol can efficiently identify primordial follicle 
fluorescence in populated areas and in close proximity to other fluorescent 
structures. Overall, Figure 3.6 highlights the abilities of the optimised uniform 
image processing protocols to efficiently identify putative primordial follicles to 
produce uniform fluorescence quantification outputs regardless of disparities in 











Figure 3.6:Comparison of fluorescence quantification outputs with original images to assess image processing efficacy 
A) Ddx4CreTg/0-LoxPtdTomato Tg/0 fluorescent ovary image exhibiting low fluorescent primordial follicle population. B) Overlay of fluorescent 
image(from A) with fluorescence quantification output displaying the efficacy of image processing protocol as a tool to identify primordial 
follicles.  C) Magnification of B (white box) illustrating image processing efficacy in identifying all putative primordial follicles. D) Ddx4CreTg/0-
LoxPtdTomato Tg/0 fluorescent ovary image exhibiting high fluorescent primordial follicle population. E) Overlay of fluorescent image(from D) 
with fluorescence quantification output displaying the efficacy of image processing protocol as a tool to identify primordial follicles F) 
Magnification of E (white box) illustrating image processing efficacy in multiple focal planes.  (Scale = 250µm)
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Comparisons of collected data to assess efficacy of 
proposed fluorescent model 
 
Stereological primordial follicle counts were correlated against the fluorescence 
quantification area measurements (Fig. 3.7A) The Pearson Correlation co-efficient 
(r) which assesses the strength of the linear relationship was r=0.8783 (p<0.0001), 
a strong correlation.  This illustrates fluorescent image quantification as an 
effective marker of ovarian reserve size.  
 
Manual primordial follicle counts from fluorescent images were correlated against 
the automated fluorescence quantification area measurements (Fig. 3.7B) The 
Pearson Correlation co-efficient (r) which assesses the strength of the linear 
relationship was r=0.9395 (p<0.0001), a strong correlation.  These results 
illustrate the ability of the image processing protocol to uniformly identify 
primordial follicles on fluorescent images to the same degree of manual human 
counting. This highlighted the efficacy of the image processing protocol to identify 
primordial follicles uniformly.  
 
Stereological primordial follicle counts were correlated against manual primordial 
follicle counts from fluorescent images (Fig. 3.7C) The Pearson Correlation co-
efficient (r) which assesses the strength of the linear relationship was r=0.7501 
(p<0.0031). This correlation is lower than both of those above. Both of these 
counts were performed manually increasing the probability of error. This increased 
margin of error using manual quantification could result in this the lower r-value.  
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Stereological primordial follicle counts were correlated against stereological 
primary follicle counts (more like a results sentence)  (Fig. 3.7D). The 
Pearson Correlation co-efficient (r) which assesses the strength of the linear 
relationship was r=0.9549 (p<0.0114), a very strong correlation.  These results are 
consistent with the literature, high variability in ovarian reserve size exists between 
individuals however the relationship between primordial and primary follicle counts 
is constant (Richardson et al. 1987). This strong correlation mitigates the issues in 
not being able to accurately identify between the fluorescence of primordial and 
primary follicles in image processing protocols.  













A) Two-tailed Pearson Correlations of Fluorescence Quantification and Stereological Primordial Follicle Counts (n=13 
p<0.0001) 
B) Two-tailed Pearson Correlations of Fluorescence Quantification and Image Primordial Follicle Counts (n=13 
p<0.0001) 
C) Two-tailed Pearson Stereological Primordial Follicle Counts and Image Primordial Follicle Counts ( n=13 p<0.0031) 




Figure 3.7: Comparisons Fluorescence Quantification, Stereological Primordial and Primary Follicle Counts 
and Image Primordial Follicle Counts to assess efficacy of Ddx4CreTg/0-LoxPtdTomatoTg/0 model 
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3.5 Comparisons of AMH serum concentrations to 
assess proposed fluorescent model with current 
ovarian reserve marker.  
 
AMH is produced by the granulosa cells of developing follicles and its serum 
concentration is known to closely correlate to the antral follicle count (AFC) 
(Baarends et al. 1995, Kevenaar et al. 2006). Figure 3.8A illustrates the very 
strong correlation (r=0.9743 (p<0.0001)) observed between the developing follicle 
counts and AMH ELISA data which is consistent with the literature and the 
dependent relationship of these two variables. 
   
The number of developing follicles correlates strongly to primordial follicle counts 
in mice aged 4-18 months (Kevenaar et al. 2006). AMH as a marker of ovarian 
reserve uses this correlative relationship to infer ovarian reserve size. This 
putative correlation of AMH and ovarian reserve size was not observed. AMH 
does not correlate with stereological primordial follicle counts in P25 Ddx4CreTg/0-
LoxPtdTomatoTg/0 mice (Fig. 3.8B) (r2=0.3562 (p<0.0313)).  
 
Figure 3.8C illustrates the comparison of AMH serum concentrations and 
automated fluorescence quantification data. The p=0.1221 is not significant which 
illustrates the lack of relationship between the two variables. The lack of 
relationship between these two variables is consistent with observed correlation 
between automated fluorescence quantification data and ovarian reserve and the 
lack of relationship between AMH and ovarian reserve in the in Ddx4CreTg/0-
LoxPtdTomatoTg/0 model.   
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A) Two-tailed Pearson Correlation of serum AMH concentrations (ng/mL) and Developing Follicle Counts (p<0.0001; n=8; 5 data points are 
average of both ovaries for those samples, n=3 is datum from a single ovary due to technical difficulties). 
B) Two-tailed Pearson Correlation of serum AMH concentrations (ng/mL) and Stereological Primordial Follicle Counts (p<0.0001; n=8; 5 data 
points are average of both ovaries for those samples, n=3 is datum from a single ovary due to technical difficulties).  
C) Two-tailed Pearson Correlation of serum AMH concentrations (ng/mL) and Fluorescence Quantification (p<0.1221; n=8; 5 data points are 
average of both ovaries for those samples, n=3 is datum from a single ovary due to technical difficulties)(not significant) 
 
 






The Ddx4CreTg/0-LoxPtdTomatoTg/0  fluorescent model of the ovarian reserve 
illustrates the efficacy of primordial follicle fluorescence as a correlative transgenic 
marker of the ovarian reserve. This presents a novel method to be able to study 
the ovarian reserve longitudinally, for the first time.  
 
These experimentations highlight the ability of the image processing protocol 
outlined in this study to quantify putative primordial follicle fluorescence as a 
correlative measure of primordial follicle population.   
 
This study also illustrates that AMH is not an appropriate marker of ovarian 
reserve size in early life in mice. 
 
4.1.1 The Ddx4CreTg/0-LoxPtdTomatoTg/0  fluorescent model for a 
longitudinal measure of the ovarian reserve 
 
Using the novel Ddx4CreTg/0-LoxPtdTomatoTg/0  fluorescence quantification as a 
transgenic biomarker, a longitudinal study of the ovarian reserve is proposed. 
Primordial follicle fluorescence as a transgenic biomarker of ovarian reserve in 
early life (P25) to be imaged during surgery. These individuals will then reproduce 
and at 14 months (approximate age of loss of oestrus cycle) will be sacrificed for 
stereological primordial follicle counts (Kevenaar et al. 2006). Spearman’s rank 
correlation can then be used to compare ovarian reserve in early and in later life in 
the same animal. Proposed rank correlations would allow for determination if 
those with high initial OR still exhibit higher primordial follicle populations in later 
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life compared to their initial low OR counterparts. Thus allowing for the 
characterisation of the influence of initial ovarian reserve size on reproductive 
longevity, for the first time longitudinally. 
 
4.2 Limitations of current knowledge of ovarian reserve 
 
The quiescent nature of the ovarian reserve results in a lack of appropriate 
markers and models for study. The current knowledge of the ovarian reserve is a 
result of histological data sets which use cross-sectional data to extrapolate data 
points and create models of ovarian reserve decline and indirect biomarkers of 
ovarian reserve.  
 
4.2.1 Cross-sectional histological analyses  
 
Data on true primordial follicle counts are exclusively from stereological counts 
from donated whole ovary tissue, from surgery or autopsy (Broekmans et al. 
2009).  This results in primordial follicle population data from a single time point 
which is extrapolated alongside other samples to produce mathematical models of 
ovarian reserve depletion which best fits the histological data (Baker & Zuckerman 
1963, Block 1952, Block 1953, Gougeon & Chainy 1987, Richardson et al. 1987).  
Menopause is also often used often as a retrospective marker to infer previous 
fertility or demographic data of menopause used as applied biological 
assumptions during model construction (Depmann et al. 2015, Faddy & Gosden 
1996).  
 
Published histological studies of ovarian reserve are often reviewed or combined 
to create new models of ovarian reserve depletion with age. Different studies are 
often inconsistent in their methodologies for example, variations in applied 
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correction methods for counting and even slight differences between classification 
of primordial follicles (Hansen et al. 2008, Wallace & Kelsey 2010). Thus, in 
models which collate previous published histological data for improved ovarian 
reserve depletion models, assumptions and correction factors are made so that 
this data can be reasonably comparative.  
 
The models of rates of ovarian reserve depletion are constantly changing. 
Collated histological human ovarian reserve data was used to produce a model 
that concluded that an accelerated rate of primordial follicle activation occurred at 
~37, just prior to average infertility onset. The proposed bi-phasic model was 
claimed to be more consistent with histological data and observed menopausal 
onset in the population, stating that proposed consistent activation rates would 
suggest menopausal onset at ~71 (Faddy et al. 1992). This model was thus a 
putative mechanism for changes to fertility, suggesting that the accelerated 
activation out of the reserve induced infertility.  
 
A later study disputed this, using new histological data from whole ovary donations 
at different ages. It was stated that the rate of primordial follicle activation 
consistently increased with age and that this depletion model was more consistent 
with the slow, accumulative biological mechanism of aging (Hansen et al. 2008).  
This highlights a weakness of cross-sectional studies as similar histological data 
can produce very different models.  
 
The Wallace and Kelsey model of ovarian reserve depletion (2010) collated the 
most human histological data on human primordial follicle counts than ever before 
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to create the first mathematical model looking at ovarian reserve depletion from 
conception to menopause. They disputed previous depletion models and 
proposed a model of increased ovarian reserve activation rate in the lead up to 
puberty (~14) and then a decreased activation rate to menopause (Wallace & 
Kelsey 2010). This data implicated pubertal onset, the activation of the 
hypothalamic-pituitary axis and onset of ovulation, as a factor slowing the rate of 
follicular recruitment from the ovarian reserve. This is consistent with the known 
role in regulating primordial follicle activation of some paracrine and endocrine 
factors, for example AMH (Knight & Glister 2006).  
 
The Wallace-Kelsey model (2010) was constructed based off of the assumption 
that the peak initial ovarian reserve size determines the age of menopausal onset 
so that women with low initial primordial follicle populations will undergo 
menopausal onset earlier than those with initial high primordial follicle populations. 
Considering the variations of both initial ovarian reserve size and age at 
menopausal onset in the population, this is reasonable. Alongside this, the lack of 
non-invasive methods to quantify ovarian reserves at an individual level in addition 
to the lack of longitudinal ovarian reserve data results in no data to either support 
or dispute this assumed relationship. This illustrates the required use of 
assumptions and inferences currently required to study ovarian reserve depletion 
from cross-sectional data.  
 
All models use the histological data sets of the ovarian reserve but produce 
conflicting models of depletion which all mathematically fit the data and are 
biologically plausible. Studies have tried to improve on previous models which has 
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included increased sample sizes and additional assumptions but the cross-
sectional nature of the data is constant. This produces conflicting results and the 
lack of longitudinal measures does not allow for assessment of which is most 
correct.   
 
The proposed Ddx4CreTg/0-LoxPtdTomatoTg/0 fluorescent model for longitudinal 
measures of the ovarian reserve outlined above would aim to characterise the 
contribution of initial ovarian reserve size on age at exhaustion thus removing 
assumptions from these models. Removing the assumption of the relationship 
between high initial ovarian reserve and later ovarian reserve depletion would 
allow for more accurate investigation of ovarian reserve depletion rates with age.  
Increased understanding of the main determining mechanisms of ovarian reserve 
depletion will improve fertility counselling services and predicting menopausal 
onset to mitigate health risks associated with the loss of endogenous oestrogens.  
 
4.2.2 Indirect ovarian reserve biomarkers.  
 
In adult mammalian females, AMH is produced exclusively by the granulosa cells 
of developing follicles (Broer et al. 2014, Monniaux et al. 2014). Thus a strong 
correlation between AMH and antral follicle count in adulthood is well reported. 
AMH levels decrease with age and this is observed as a result of decreased 
developing counts as each follicle still produce the same level of AMH (Kevenaar 
et al. 2006). Amh–/– mice experience premature depletion of their ovarian 
reserves, implicating AMH as a regulator of primordial follicle activation rates 
(Carlsson et al. 2006, Durlinger et al. 2002, Durlinger et al. 1999). This 
relationship suggests that the size of the developing follicle pool represents the 
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size of the ovarian reserve so AMH is often used clinically as an indirect 
correlative marker of ovarian reserve. 
 
In humans, AMH levels are low at birth and increase to a peak concentration at 
~25 years of age and then decline till menopause (Fleming et al. 2012, Hagen et 
al. 2010, Kelsey et al. 2011). This results in AMH as an ovarian reserve marker 
only after this peak period at ~25 (Fleming et al. 2012). AMH expression declines 
with age from ~4 months in mice but early life AMH expression has not been well 
characterised (Kevenaar et al. 2006).  
 
The lack of correlation between AMH and ovarian reserve in Ddx4CreTg/0-
LoxPtdTomatoTg/0  fluorescent model highlights that AMH is not an efficient 
biomarker of ovarian reserve in young mice. Thus, for proposed longitudinal 
studies to investigate if initial reproductive size is the main determinant in the 
onset of reproductive senescence, AMH is not an appropriate ovarian reserve 
marker. The Ddx4CreTg/0-LoxPtdTomatoTg/0  transgenic biomarker of ovarian 
reserve correlated with ovarian reserve in early age and is therefore an 
appropriate marker moving forward in future proposed experimentation to assess 
the main determinants of ovarian reserve depletion. 
 
4.3 Recombination events of Ddx4Cre-LoxPtdTomato 
model 
 
Previously, sperm was proposed to only contribute DNA and acrosomal machinery 
for zona pellucida during fertilisation. Recent studies have shown that sperm can 
contribute RNA to the zygote, most studies have focused on short interfering RNA 
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transfer (Hosken & Hodgson 2014). The global recombination effect in the 
Ddx4CreTg/0-LoxPtdTomatoTg/0 model is not fully penetrant in young fathers, 
suggesting that the incidence of sperm RNA transfer increases with paternal age. 
This results in Cre-recombinase presence in the zygote and the premature 
recombination of LoxPtdTomato resulting in tdTomato expression throughout all 
tissues.  
  
Testosterone levels increase in this period between the ages of the ‘young’ and 
‘old’ fathers in this experimentation which suggests testosterone as a mechanism 
of action, however more study would be needed (Machida et al. 1981).  
 
Further characterisation of the mechanism underlying sperm mRNA transfer would 
allow for a possible mechanism to block this effect so that no mRNA is passed on 
from the father. A female germ cell specific marker would remove the uncertainty 
of Cre-recombinase transfer from the sperm. Current identified female germ cell 
specific markers are not expressed in primordial follicle oocytes, which the 
fluorescent model of the ovarian reserve requires.  However, these proposed 
remedies are not feasible with current knowledge and markers available.  
 
The partial penetrance of global recombination in Ddx4CreTg/0-
LoxPtdTomatoTg/0  offspring of young father due to sperm mRNA transfer results in 
a cohort of some Ddx4CreTg/0-LoxPtdTomatoTg/0  offspring with tdTomato 
expression exclusively in germ cells. Thus the fluorescent ovarian reserve models 
are still available for study but the fluorescent ovarian reserve phenotype at a 
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reduced rate to Ddx4CreTg/0-LoxPtdTomatoTg/0  genotypes, as some individuals 
globally recombine.  
 
4.4 Strengths and Limitations of the model 
 
4.4.1 Image Processing Efficacy 
 
Image processing protocol, with sufficient training was able to efficiently identify 
primordial follicles, even on images of varying fluorescent intensities. Optimisation 
of image processing protocols allowed for strong correlations of resultant 
automated fluorescence quantifications to stereological and manual image 
primordial counts illustrating that Ddx4CreTg/0-LoxPtdTomatoTg/0 primordial follicle 
fluorescence is an effective transgenic biomarker for the ovarian reserve.  
 
4.5 Human vs. machine 
 
Image processing protocol of the Ddx4CreTg/0-LoxPtdTomatoTg/0  fluorescent 
model has a machine learning component which minimises bias as all samples 
were treated uniformly using a combination of algorithms. To assess the efficacy 
of these fluorescent quantifications and thus the model, correlations to manual 
primordial follicle counts (stereological and image) were performed.  
 
Comparison of manual image primordial follicle counts and stereological 
primordial follicle counts showed a correlation of r=0.75. This is a strong 
correlation but a weaker relationship than each variable compared to automated 
fluorescence quantification. The manual nature of these counts introduced human 
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error and bias. To determine which of these counts is more correct, tissue clearing 
could be used.   
 
4.6 Tissue Clearing 
 
Tissue clearing by CLARITY is a method which transforms intact tissue into a 
transparent hybrid of tissue and hydrogel that preserves structures allowing for 
investigation of whole intact  tissue. This method is compatible with 
immunohistochemistry and allows for tissue to undergo multiple rounds of staining 
and de-staining to allow for investigation of multiple tissue components (Chung et 
al. 2013, Du et al. 2018).  Tissue clearing by CLARITY presents a method for 
further examination of the relationship between primary and primordial follicles 
and their fluorescence in the intact Ddx4CreTg/0-LoxPtdTomatoTg/0  ovary.  
 
The fluorescent model assumes that all germ cells are expressing Ddx4 and 
therefore Cre-recombinase has recombined tdTomato for fluorescence expression 
in every oocyte. This assumption results in the attribution of the variability in our 
fluorescence quantification to be due to variation in primordial follicle counts. To 
confirm this, immunohistochemistry could be performed by CLARITY to stain for 
both Ddx4 and tdTomato to test if all germ cells express Ddx4-Cre and thus 
tdTomato fluorescence.  This would be beneficial in further characterising the 
transgenic model of the ovarian reserve.  
 
Tissue clearing by CLARITY could also be further examine the relationship 
between primordial and primary follicle counts, due to the inabilities to always 
distinguish between them in fluorescence. The strong correlation observed in 
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experimentation could be further strengthened by immunohistochemical staining 
of Zona pellucida glycoprotein 3 (Zp3). Zp3 is expressed by oocytes after 
activation out of the ovarian reserve and thus are markers of developing follicles 
(de Vries et al. 2000, Epifano et al. 1995). First tissue cleared ovary could be 
stained for Ddx4 and tdTomato to assess efficacy of recombination followed by 
Zp3 staining to differentiate between primordial and primary follicles.  
 
4.6.1 Surgical approach 
Imaging the Ddx4CreTg/0-LoxPtdTomatoTg/0  fluorescent ovaries in early life in vivo 
by minimally invasive surgical approach with minimal disturbance to the animal 
represents the next step in the development of the transgenic fluorescent model of 
the ovarian reserve for longitudinal ovarian reserve depletion assessment.  
 
Oophorectomies and sham surgery controls have been extensively used in the 
field of ovarian biology illustrating that ovaries can be manipulated in surgery and 
remain functional (Blaustein et al. 1976).  
 
The Ddx4CreTg/0-LoxPtdTomatoTg/0 fluorescent ovarian images were from a single 
surface of the ovary. This will be beneficial in employing the surgical approach as 
to minimise the disturbances to the animal and ovarian structures during image 
capture.  
 
4.6.2 Variation in samples 
The variation of the ovarian reserve in the population is significant, the observed 
variation in samples of this study was relatively low. The samples used were 
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hybrids as Ddx4Cre stock males were FVB background and backcrossing was 
performed with C57BL/B6 mice therefore it was hypothesised that the sample 
population would represent overall population with a strong variance in ovarian 
reserve size.  
 
An increased range of ovarian reserve sizes for a stronger representation of 
population distributions of ovarian reserve would better assess the magnitude of 
initial ovarian reserve size impact on reproductive longevity.  Analysis of initial 
ovarian reserve size at both high and low end will allow for better classification of 
the proposed relationship between initial ovarian reserve size and time till 
exhaustion  
 
4.6.3 Assessing the fertility of Ddx4CreTg/0-LoxPtdTomatoTg/0 model 
To study ovarian reserve alongside fertility, it would first need to be determined if 
the transgenes had any effect on fertility. This would be assessed by pairings of 
Ddx4CreTg/0-LoxPtdTomatoTg/0 females with wildtype males. The fertility of these 
individuals would be analysed alongside Ddx4CreTg/0-LoxPtdTomato0/0 females 
with wildtype male pairings (for cre-recombinase toxicity assessment) as well as 
Ddx4Cre0/0-LoxPtdTomato0/0 female littermates with male wildtype pairings. These 
experiments would determined if Ddx4Cre and LoxPtdTomato transgenes affect 
fertility. This would ensure that the observed relationship between initial ovarian 
reserve size and reproductive longevity using this new proposed transgenic 






The Ddx4CreTg/0-LoxPtdTomatoTg/0 fluorescence model of the ovarian reserve 
illustrates a strong correlation with stereological primordial follicle counts 
representing a novel transgenic biomarker of the ovarian reserve in young mice.  
 
Using this transgenic biomarker, a longitudinal study of the ovarian reserve is 
proposed. Primordial follicle fluorescence as a transgenic biomarker of ovarian 
reserve in early life (P25) is to be rank correlated to stereological primordial follicle 
counts in later life at loss of fertility, in the same individuals. Proposed rank 
correlations would allow for determination if those with high initial OR still exhibit 
higher primordial follicle populations in later life compared to their initial low OR 
counterparts.   
 
Thus, this model represents an early step in allowing for the determination of the 
contribution of initial ovarian reserve size to reproductive longevity in the mouse, 
for the first time. The resultant relationship could be then be used to further study 
the implications of rates of primordial activation with age and to further 
characterise the links between lifestyle factors (eg. Smoking, parity and BMI) on 
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